DEFY IT Health Compares Level-Up and Respawn Products

DEFY IT Health Kratom: Level-Up vs. Respawn, What’s the Difference?

As interest in whole-leaf kratom and its 7-OH content continues to influence buyer research, DEFY IT Health has released a detailed comparison of its Level-Up and Respawn products. This analysis examines the key differences, including pricing, ingredients, and potential regulatory implications.

DEFY IT Health, a brand marketed under ETHA, offers two whole-leaf kratom tablet formulas: Level-Up and Respawn. Both are described by the company as supporting focus and endurance, and recovery and reset, respectively. However, the distinction between the two is primarily in their brand framing rather than in their active ingredients or packaging.

Ingredients and Active Ingredients

Both Level-Up and Respawn contain 300 mg of Mitragyna speciosa leaf per 500 mg tablet. The company markets this as the natural alkaloid profile of the plant, without isolating or concentrating specific compounds. According to DEFY IT, its tablets keep 7-hydroxymitragynine, or 7-OH, at naturally occurring trace levels, distinguishing them from extracts that may contain higher, concentrated 7-OH content. This distinction is relevant given the recent regulatory scrutiny of concentrated 7-OH products.

Pricing and Availability

At the time of this review, the pricing for both Level-Up and Respawn varied slightly. DEFY IT’s landing page listed the following prices: - Level-Up: $17.49 for 30 grams (100 tablets) - Respawn: $17.49 for 30 grams (100 tablets)

However, the ETHA checkout page listed slightly higher prices: - Level-Up: $18.49 for 30 grams (100 tablets) - Respawn: $18.49 for 30 grams (100 tablets)

Consumers are advised to confirm the live prices before purchasing.

Testing and Certificates of Analysis

DEFY IT claims that its batches are pasteurized, filtered, and tested for purity. Certificates of analysis are accessible via QR code or bag number on the packaging. While this provides a mechanism for consumers to review batch-specific documentation, it does not guarantee the absence of contaminants or clinical effectiveness. The company did not independently verify a specific batch’s COA for this review.

Regulatory Compliance and Claims

DEFY IT markets its products as "DSHEA and KCPA compliant," but DSHEA compliance does not equate to FDA approval. The Kratom Consumer Protection Act (KCPA) is a model legislation adopted by individual states with varying terms, so a "KCPA compliant" claim does not specify which state's version, if any, is being referenced.

DEFY IT claims that its tablets provide smooth-onset energy, centered focus, and physical recovery that feels earned. However, none of these statements have been evaluated by the FDA.

Conclusion

For individuals considering DEFY IT’s Level-Up and Respawn, the key differences lie in the brand’s marketing positioning rather than in the active ingredients or performance outcomes. Consumers should carefully review the pricing, ingredients, and regulatory compliance claims, and consider consulting with a healthcare provider before making a decision.